Two recent meta-analyses that included 5655 and 2470 PTC patients, respectively, found a significant association between the BRAF mutation and lymph node metastasis, extrathyroidal extension, advanced tumor stage and recurrence [15], [16]. This evidence concerns the gene BRAF and neoplasm.